InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Tuesday, 05/19/2020 7:10:09 AM

Tuesday, May 19, 2020 7:10:09 AM

Post# of 232771
Look at this effect - paper published in nature SP up by 32%. The paper has data from one patient - no control group.

One key difference - the co has collaboration with GSK


Shares of Vir Biotechnology (NASDAQ:VIR) soared on Monday after the company announced some exciting news regarding its efforts to develop a treatment for COVID-19. Specifically, promising research findings from Vir's attempts to defeat COVID-19 were published in a paper in the journal Nature, one of the world's leading science journals. Vir's stock closed the day up by 32.1%


https://www.fool.com/investing/2020/05/18/why-vir-biotechnology-rocketed-higher-today.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News